The efficacy of this treatment [86] thus provides further indication of the involvement of TLRs in the pathogenesis of SLE and justifies the on-going research efforts in developing new therapies based on targeting TLR7 and 9. The gene discussed is TLR7; the disease is systemic lupus erythematosus.